Low-grade developmental and epilepsy associated brain tumors: a critical update 2020

被引:110
|
作者
Slegers, Rutger Juriaan [1 ]
Blumcke, Ingmar [2 ]
机构
[1] Maastricht Univ, Fac Hlth Med & Life Sci, Univ Singel 40, NL-6229 ER Maastricht, Netherlands
[2] Univ Hosp Erlangen, Dept Neuropathol, Schwabachanalge 6, D-91054 Erlangen, Germany
关键词
Pathology; Seizure; Ganglioglioma; Astrocytoma; Oligodendroglioma; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; CENTRAL-NERVOUS-SYSTEM; VACUOLATING NEURONAL TUMOR; GENETIC ALTERATIONS; MOLECULAR CHARACTERIZATION; MALIGNANT-TRANSFORMATION; CONSENSUS CLASSIFICATION; EPILEPTOGENIC NEOPLASM; V600E MUTATION; SEIZURES;
D O I
10.1186/s40478-020-00904-x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain tumors represent the second most frequent etiology in patients with focal seizure onset before 18 years of age and submitted to epilepsy surgery. Hence, this category of brain tumors, herein defined as low-grade, developmental, epilepsy-associated brain tumors (LEAT) is different from those frequently encountered in adults as (A): 77% of LEAT occur in the temporal lobe; (B): the vast majority of LEAT are of low malignancy and classified as WHO I degrees; (C): LEAT are often composed of mixed glial and neuronal cell components and present with variable growth patterns including small cysts or nodules; (D): LEAT do not share common gene driving mutations, such as IDH1 or 1p/19q co-deletions. Characteristic entities comprise the ganglioglioma (GG), the dysembryoplastic neuroepithelial tumor (DNT), the angiocentric glioma (AG), the isomorphic diffuse glioma (IDG) and the papillary glio-neuronal tumor (PGNT), representing 73.2% of 1680 tumors collected in a large German series of 6747 patients submitted to epilepsy surgery. In the realm of exciting discoveries of genetic drivers of brain tumors new genes have been also reported for LEAT. BRAF V600E mutations were linked to GG with CD34 expression, FGFR1 mutations to DNT, MYB alterations to AG and also IDG and PRKCA fusions to PGNT, suggesting the possibility to also develop a genetically driven tumor classification scheme for LEAT. Rare availability of LEAT in a single center is a challenging obstacle, however, to systematically unravel the neurobiological nature and clinical behavior of LEAT. Other challenges in need of clarification include malignant tumor progression of LEAT entities, seizure relapse in patients following bulk tumor resection and the controversial issue of associated focal cortical dysplasia as additional pathomechanism. In order to advance our understanding and promote reliable diagnostic work-up of LEAT, we recommend, therefore, international collaboration to achieve our goals.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The impact of low-grade brain tumors on verbal fluency performance
    Goldstein, B
    Obrzut, JE
    John, C
    Hunter, JV
    Armstrong, CL
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2004, 26 (06) : 750 - 758
  • [32] Relationship between focal cortical dysplasia and epilepsy-associated low-grade tumors: an immunohistochemical study
    Marucci, Gianluca
    Martinoni, Matteo
    Giulioni, Marco
    APMIS, 2013, 121 (01) : 22 - 29
  • [33] Low-grade epilepsy-associated neuroepithelial tumors: Tumor spectrum and diagnosis based on genetic alterations
    Xie, Mingguo
    Wang, Xiongfei
    Duan, Zejun
    Luan, Guoming
    FRONTIERS IN NEUROSCIENCE, 2023, 16
  • [34] Seizure-outcome after surgery of low-grade epilepsy associated neuro-epithelial tumors
    Mehrotra, Anant
    Singh, Suyash
    Kanjilal, Soumen
    Pal, Lily
    Paliwal, Vimal K.
    Sardhara, Jayesh
    Behari, Sanjay
    JOURNAL OF NEUROSURGICAL SCIENCES, 2020, 67 (05) : 591 - 597
  • [35] CD34 Expression in Low-Grade Epilepsy-Associated Tumors: Relationships with Clinicopathologic Features
    Giulioni, Marco
    Marucci, Gianluca
    Cossu, Massimo
    Tassi, Laura
    Bramerio, Manuela
    Barba, Carmen
    Buccoliero, Anna Maria
    Vornetti, Gianfranco
    Zenesini, Corrado
    Consales, Alessandro
    De Palma, Luca
    Villani, Flavio
    Di Gennaro, Giancarlo
    Vatti, Giampaolo
    Zamponi, Nelia
    Colicchio, Gabriella
    Marras, Carlo Efisio
    WORLD NEUROSURGERY, 2019, 121 : E761 - E768
  • [36] Tryptophan metabolism in brain tumors associated with epilepsy: Imaging and immunohistochemistry analysis of low and high-grade tumors
    Batista, Carlos E.
    Juhasz, C.
    Kupsky, W. J.
    Chugani, H. T.
    Barger, G.
    Muzik, O.
    Chugani, D. C.
    EPILEPSIA, 2007, 48 : 273 - 274
  • [37] The landscape of common genetic drivers and DNA methylation in low-grade (epilepsy-associated) neuroepithelial tumors: A review
    Jesus-Ribeiro, Joana
    Rebelo, Olinda
    Ribeiro, Ilda Patricia
    Pires, Luis Miguel
    Melo, Joao Daniel
    Sales, Francisco
    Santana, Isabel
    Freire, Antonio
    Melo, Joana Barbosa
    NEUROPATHOLOGY, 2022, 42 (06) : 467 - 482
  • [38] Clinical management of epilepsy associated with low-grade glioma and literature review
    Xu, Xinke
    Li, Fangcheng
    PEDIATRIC MEDICINE, 2022, 5 : 1 - 6
  • [39] Predicting vocational outcome among patients with low-grade brain tumors
    Lowry, JB
    Giovannetti, T
    Armstrong, C
    Chute, D
    Shera, D
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2004, 19 (07) : 945 - 945
  • [40] EVALUATION OF COBIMETINIB, A MEK INHIBITOR, IN LOW-GRADE PEDIATRIC BRAIN TUMORS
    Roskoski, Martin
    Gasinski, Danuta
    Friedman, Henry
    Bigner, Darell
    Keir, Stephen
    NEURO-ONCOLOGY, 2018, 20 : 104 - 105